Agitation Clinical Trials

5 recruiting

Frequently Asked Questions

Common questions about Agitation clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Phase 3

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

Alzheimer DiseaseAgitation
Bristol-Myers Squibb600 enrolled241 locationsNCT06937229
Recruiting
Phase 2Phase 3

Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

Agitation Associated With Alzheimer's Disease Dementia
Exciva GmbH300 enrolled13 locationsNCT07284472
Recruiting
Phase 3

Nabilone for Agitation Blinded Intervention Trial

Alzheimer DiseaseAgitation
Sunnybrook Health Sciences Centre112 enrolled6 locationsNCT04516057
Recruiting
Phase 2

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Alzheimer DiseaseAgitation
Celgene120 enrolled52 locationsNCT06808984
Recruiting
Phase 2

Clinical Trial on Agitation in Alzheimer's Dementia

Alzheimer DiseaseAggressionAgitation,Psychomotor+2 more
IGC Pharma, LLC164 enrolled28 locationsNCT05543681
Recruiting
Phase 2

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia

Agitation Associated With Alzheimer's Dementia
Intra-Cellular Therapies, Inc.320 enrolled69 locationsNCT06651567
Recruiting
Phase 3

Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type

AgitationAlzheimer's Type Dementia
Suven Life Sciences Limited375 enrolled44 locationsNCT05397639
Recruiting
Phase 2

Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type

Agitation
Teikoku Pharma USA, Inc.150 enrolled3 locationsNCT06052254
Recruiting
Phase 2

A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia

Agitation Associated With Alzheimer's Disease Dementia
Ono Pharmaceutical Co. Ltd90 enrolled38 locationsNCT06803823
Recruiting
Phase 2

Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.

Alzheimer DiseaseAgitation in Dementia
Bernard (Barry) Baumel8 enrolled1 locationNCT06781333
Recruiting
Early Phase 1

Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia

AnxietyAlzheimer DiseaseMild Cognitive Impairment (MCI) Due to Alzheimer's Disease+1 more
Mclean Hospital12 enrolled1 locationNCT04075435
Recruiting
Not Applicable

Virtual Darkness Theraphy for Agitation in Dementia

Agitation in Dementia, Including Alzheimer's Disease
University of Bergen72 enrolled1 locationNCT06451952
Recruiting

Safe Brain Initiative, Operationalizing Precision Anaesthesia

PainStressAnxiety+14 more
University of Southern Denmark15,000 enrolled1 locationNCT05765162
Recruiting
Not Applicable

Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)

Alzheimer DementiaAgitation,Psychomotor
Brent Forester50 enrolled5 locationsNCT03926520